Retatrutide txhaj 10 mg yog ib qho hnyav-cov tshuaj poob uas tab tom txhim kho. Nws ua haujlwm los ntawm kev ua zoo li peb lub plab cov tshuaj hormones uas pab kom sib npaug qab los noj mov thiab cov metabolism. Qhov tseem ceeb ntawm kev tsim kho tshiab ntawm retatrutide nyob hauv nws qhov tshwj xeeb triple receptor agonist mechanism. Raws li 39-amino acid hluavtaws peptide, nws cov qauv tsim molecular ua tiav 6- hnub ib nrab- lub neej los ntawm succinyl- diacetyl coupling, ua rau ib zaug - txhaj tshuaj txhua lub lim tiam. GLP-1 receptor activation: txo qis qab los noj mov, qeeb plab hnyuv plab, thiab txhawb kev tso tawm insulin, tsim lub hauv paus rau kev poob phaus thiab tswj glycemic. GIP receptor activation: Txhim kho insulin rhiab heev, tswj cov lipid metabolism, thiab txhim kho cov rog rog. Glucagon receptor activation: Ntxiv dag zog rau kev siv nyiaj thiab roj oxidation, txo cov rog hauv siab, thiab txhawb lipolysis. Qhov no triple -lub hom phiaj sib koom ua ib lub voj voog kaw ntawm "qab los noj mov-metabolic acceleration-tiv thaiv lub cev." Cov kev tshawb fawb ua ntej pom tau hais tias kev ua kom muaj peb zaug tuaj yeem txhim kho lub zog ntawm cov metabolism hauv ntau dua 30%, txo cov ntaub so ntswg adipose txog li 83%, thaum khaws cia cov nqaij ntshiv ntawm lub cev thiab zam cov nqaij ntshiv uas cuam tshuam nrog kev poob phaus.
Peb Cov Khoom Muag Khoom
Retatrutide COA
 |
||
| Certificate of Analysis | ||
| Compound npe | Retatrutide | |
| Qib | Pharmaceutical qib | |
| CAS Nr. | 2381089-83-2 | |
| Ntau | 3 37,3kg | |
| Ntim txheem | 25kg / nruas | |
| Chaw tsim tshuaj paus | Shaanxi BLOOM TECH Co., Ltd | |
| Ntau No. | 202510090025 | |
| MFG | Peb 9, 2025 | |
| EXP | Peb 8, 2028 | |
| Qauv | N/A | |
| Yam khoom | Enterprise txheem | Kev txheeb xyuas qhov tshwm sim |
| Qhov tshwm sim | Dawb los yog yuav luag dawb hmoov | Ua raws |
| Cov ntsiab lus dej | Tsawg dua lossis sib npaug li 5.0% | 0.38% |
| Poob rau ziab | Tsawg dua lossis sib npaug li 1.0% | 0.26% |
| Hnyav Hlau | Pb Tsawg dua lossis sib npaug li 0.5ppm | N.D. |
| Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Hg Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Cd Tsawg dua lossis sib npaug li 0.5ppm | N.D. | |
| Purity (HPLC) | Ntau dua lossis sib npaug li 99.0% | 99.90% |
| Ib leeg impurity | <0.8% | 0.39% |
| Tag nrho microbial suav | Tsawg dua lossis sib npaug li 750cfu / g | 80 |
| E. Coli | Tsawg dua lossis sib npaug li 2MPN / g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (los ntawm GC) | Tsawg dua lossis sib npaug li 5000ppm | 400ppm ua |
| Cia | Khaws rau hauv qhov chaw kaw, tsaus, thiab qhuav hauv qab -20 degree | |
|
|
||
Drug Overview and Mechanism Innovation
Retatrutide, lub ntiaj teb thawj triple receptor agonist tsom GLP-1, GIP, thiab glucagon, muab cov teebmeem kev poob phaus los ntawm nws cov 10mg txhaj tshuaj los ntawm kev ua kom peb cov metabolism hauv cov receptors.
Qhov no 39-amino acid tshuaj molecule nta C20 fatty acid hloov kho uas txuas nws ib nrab- lub neej mus rau 6 hnub, ua kom muaj kev txhaj tshuaj subcutaneous ib lim piam.
Nws cov txheej txheem triple tsim ib qho kaw- lub voj kaw lus ntawm "qab los noj mov- metabolic acceleration-kev tiv thaiv hauv nruab nrog cev": GLP-1 receptor activation qeeb lub plab khoob thiab txhawb nqa cov tshuaj insulin secretion; GIP receptor activation txhim kho insulin rhiab heev thiab tswj cov lipid metabolism; glucagon receptor activation txhawb lipolysis thiab kev siv hluav taws xob.
Qhov kev sib koom ua ke no tau ua tiav qhov hnyav nruab nrab ntawm 24.2% hauv Phase II kev sim, mus txog qhov ua tau zoo ntawm kev phais plab hnyuv, thaum tib lub sijhawm txhim kho ntau qhov ntsuas metabolic suav nrog cov ntshav qabzib, lipids, ntshav siab, thiab cov rog rog rog.
Precision Strategies rau Indication Screening
Raws li kev pom zoo kho mob zaum kawg, Retatrutide feem ntau qhia rau cov neeg mob uas muaj kev rog yooj yim (BMI Ntau dua lossis sib npaug li 30) lossis cov neeg uas muaj BMI Ntau dua lossis sib npaug li 27 uas tseem muaj teeb meem xws li metabolic syndrome, ntshav qab zib hom 2, tsis yog - cawv fatty siab kab mob, lossis obstructive pw tsaug zog apnea. Cov txheej txheem kev xaiv no yog nyob ntawm Phase III TRIUMPH-4 cov ntaub ntawv sim, uas pom tau tias txo qis kev txiav txim siab hauv cov neeg mob rog rog (piv txwv li BMI Ntau dua lossis sib npaug li 35) piv rau cov pab pawg BMI qis, qhia tias muaj kev tiv thaiv ntau dua thiab muaj txiaj ntsig hauv cov neeg muaj BMI siab. Hauv kev xyaum kho mob, kev ntsuam xyuas ntau yam yuav tsum tau ua kom paub meej tias cov cim qhia, suav nrog:
Kev ntsuas meej thiab kev soj ntsuam dynamic ntawm lub cev qhov ntsuas
Kev ntsuam xyuas ntawm cov kab mob metabolic (mob plab, hyperglycemia, ntshav siab, hypertriglyceridemia, HDL qis)
Kev tshuaj ntsuam xyuas teeb meem (lub siab / raum ua haujlwm, pob txha ntom ntom, ECG, saib xyuas pw tsaug zog)
Kev ntsuam xyuas kev puas siab puas ntsws thiab kev ntsuas tus cwj pwm coj cwj pwm
Cov neeg tshwj xeeb xav tau kev ntsuam xyuas tus kheej: Cov neeg laus laus yuav tsum xav txog cov leeg nqaij thiab kev pheej hmoo poob; cov neeg uas muaj kab mob siab lossis lub raum tsis zoo yuav tsum tau hloov cov koob tshuaj; Cov neeg mob ntshav qab zib yuav tsum tau saib xyuas lub plawv dhia thiab kev hloov ntshav siab.
Scientific Pathway for Dose Titration
01
Cov koob tshuaj titration lub tswv yim ntawm kev pib ntawm 2mg thiab nce los ntawm 2mg txhua 4 lub lis piam tau raug lees paub los ntawm Phase II / III kev sim tshuaj, ntsuas kev ua tau zoo thiab kev nyab xeeb. Cov tswv yim no yog tsim los ntawm cov yam ntxwv ntawm pharmacokinetic thiab pharmacodynamic:
Lub hom phiaj koob tshuaj yog ib tus zuj zus raws li kev ua tau zoo thiab kev kam rau siab (feem ntau 8-12mg).
Kev hloov kho koob tshuaj yuav tsum ua raws li "Saib- Ntsuam Xyuas- Kho" lub voj voog:
Saib xyuas cov kab mob plab hnyuv hauv 48 teev thaum lub sijhawm pib.
02
Thaum lub sij hawm escalation, ntsuam xyuas qhov kam rau ntawm txhua qhov increment
Thaum lub sij hawm txij nkawm, ib ntus ntsuas kev ua tau zoo thiab kev nyab xeeb
Kho titration ceev nyob rau hauv cov xwm txheej tshwj xeeb: Nthuav ncua sij hawm rau plab hnyuv- cov neeg mob rhiab heev; luv voj voog rau cov uas tsis txaus teb. Nco ntsoov tias koob tshuaj ntau tshaj 12mg qhia tsis muaj txiaj ntsig ntxiv tab sis ua rau muaj kev pheej hmoo tsis zoo.
Cov ntaub ntawv pov thawj-Raws li Kev Tshawb Fawb Txog Ntev- Lub Sijhawm Ua Tau Zoo thiab Qhov hnyav rov qab tom qab txiav tawm
Ntev -lub sij hawm ua raws- cov ntaub ntawv nce ntxiv qhia tias rettrutide tswj cov kev poob phaus ruaj khov thaum kho tas mus li, tab sis qhov hnyav rov qab tshwm sim tom qab txiav tawm.
Nyob rau ntawm 12-lub lim tiam tom qab kev kho mob 68 lub lis piam, cov neeg mob uas tsis siv txoj kev kho mob tau ntsib qhov hnyav nruab nrab ntawm 8% -10%, qis dua qhov pom nrog semaglutide (15%-20%) thiab tirzepatide (12% -18%).
Cov kev tswj xyuas kev sib txuas ua ke nrog kev cuam tshuam kev ua neej nrog kev siv tshuaj kho tau zoo txo qhov kev rov qab los.
Hais txog kev txuag cov leeg nqaij, thaum rettrutide txhawb nqa lipolysis los ntawm glucagon receptor activation, qhov kev pheej hmoo ntawm cov leeg nqaij tsis pom zoo.
Cov kev tshawb fawb tsis ntev los no qhia tau hais tias kev sib koom ua ke rettrutide nrog cov leeg nqaij - cov tshuaj tiv thaiv (piv txwv li, bimagrumab) tuaj yeem ua tiav ob qho txiaj ntsig ntawm kev poob rog thiab cov leeg nqaij.
Safety Profile thiab Risk Management Strategies
Cov kev phiv tshwm sim feem ntau: Cov kab mob plab hnyuv (xeev, raws plab, ntuav) tshwm sim hauv 60% -80% ntawm cov neeg mob, feem ntau thaum noj tshuaj nce ntxiv. Cov no tuaj yeem txo tau los ntawm kev siv tshuaj ntau zuj zus ntxiv.
Mob plawv: Lub plawv dhia nce 5-10 beats / min, systolic ntshav siab txo los ntawm 5-15 mmHg. Kev saib xyuas yog xav tau rau cov neeg mob uas muaj kab mob plawv.
Metabolic Abnormalities: Siab siab enzymes (ALT/AST) tshwm sim nyob rau hauv 3% -5% ntawm cov neeg mob, feem ntau mob me thiab thim rov qab; Lub raum tsis ua haujlwm nyob ruaj khov uas tsis muaj qhov cuam tshuam loj heev.
Neurological Effects: Kev hnov mob txawv txav tshwm sim hauv 8% -20% ntawm cov neeg mob, feem ntau mob me thiab thim rov qab thaum tsis txuas ntxiv.
Kev tswj hwm kev pheej hmoo yuav tsum muaj txoj hauv kev sib tw: cov kev cuam tshuam me me yog tswj hwm los ntawm kev hloov kho koob tshuaj thiab kho cov tsos mob; kev cuam tshuam nruab nrab yuav tsum tau txiav tawm ib ntus thiab kev ntsuam xyuas; Cov tshuaj tiv thaiv hnyav yuav tsum tau txiav tawm mus tas li thiab pib cov txheej txheem xwm txheej ceev. Cov neeg tshwj xeeb (cov laus, cov neeg mob uas muaj kab mob siab / lub raum tsis zoo, kab mob plawv) yuav tsum tau txhaj tshuaj ib leeg.
Daim ntawv thov
Retatrutide txhaj 10 mgpioneers lub sijhawm tshiab hauv kev kho mob rog dhau los ntawm nws txoj kev ua kom lub cev muaj zog triple, muab kev txhawb nqa kev phais - theem kev poob phaus thiab ntau - lub cev tiv thaiv kab mob.
Txawm li cas los xij, kev hloov pauv los ntawm kev tshawb fawb hauv chaw kuaj mob mus rau daim ntawv thov kev kho mob yuav tsum muaj kev kov yeej ntau yam teeb meem, suav nrog kev lees paub kev nyab xeeb, kev siv tau zoo, thiab kev tswj hwm kev pheej hmoo ntev ntev.
Saib tom ntej, nrog rau kev tso tawm ntawm Phase III cov ntaub ntawv thiab nthuav qhia, rettrutide tuav cov lus cog tseg raws li lub hauv paus kev kho mob rau kev rog rog thiab cuam tshuam txog cov kab mob metabolic.
Txawm li cas los xij, nws tus nqi tiag tiag yuav raug pom tsuas yog los ntawm kev paub txog kev cai lij choj thiab kev siv ceev xwm txheej. Raws li cov kws tshaj lij sau tseg: "Tsis muaj tshuaj zoo meej, tsuas yog cov tswv yim kho mob zoo tshaj plaws." Retatrutide lub hom phiaj kawg yog los kho qhov poob phaus rau nws txoj kev noj qab haus huv-qhov tseem ceeb ntawm qhov tseem ceeb- tsis yog lej game.
Hauv kev kho mob rog rog, rettrutide- lub ntiaj teb thawj triple receptor agonist tsom GLP-1, GIP, thiab glucagon- tau nthuav dav nws cov ntawv thov raws li Phase III kev sim tshuaj ntsuam xyuas kev nce qib thiab cov ntaub ntawv tiag tiag hauv ntiaj teb sib sau. Raws li Lub Ib Hlis 2026, rettrutide tau ua tiav nws txoj kev tshawb fawb thoob ntiaj teb multicenter Phase III thiab nkag mus rau theem kev pom zoo.
Nws daim ntawv thov tau nthuav dav los ntawm kev rog yooj yim mus rau kev tswj hwm ntau yam mob xws li metabolic syndrome, ntshav qab zib hom 2, tsis yog - kab mob cawv fatty siab (NAFLD), thiab kab mob plawv.
Qhov no tsim ib qho kev kho mob zoo tshaj plaws nyob rau hauv "kev poob phaus raws li lub hauv paus thiab ntau- kev tiv thaiv lub cev raws li qhov tseem ceeb.
Cov lus nug nquag
Dab tsi yog kev siv cov tshuaj rettrutide 10mg?
+
-
Retatrutide yog tsim los rau lub hom phiaj ntau yam mob metabolic, nrog rau nws cov kev siv tseem ceeb hauvKev tswj hwm kev rog, hom 2 mob ntshav qab zib, thiab kab mob siab rog.
Yuav ua li cas tshwm sim tom qab noj cov tshuaj retatrutide?
+
-
Hauv peb qhov kev tshuaj ntsuam meta-, tus nqi siab dua ntawm plab hnyuv- cuam tshuam txog cov xwm txheej tsis zoo, tshwj xeeb tshaj yogxeev siab, ntuav, thiab cem quav, ntxiv rau cov xwm txheej hypersensitivity tau pom nyob rau hauv cov neeg mob kho nrog rettrutide.
Kuv yuav poob phaus sai npaum li cas ntawm retatrutide?
+
-
Ib qho ntawm cov yam ntxwv tseem ceeb ntawm rettrutide yog qhov pib sai ntawm nws qhov hnyav - los ntawm kev poob. Hauv theem 2 mus sib hais, cov neeg koom tau pib muaj kev txo qis hauv lub cev hnyavthaum ntxov li 24 lub lis piam, nrog rau ntau dua - pawg koob tshuaj (8 mg thiab 12 mg) qhia txog kev hloov pauv tshaj plaws.
Puas yog Retatrutide zoo dua Ozempic?
+
-
Thaum rettrutide ua raws li peb cov tshuaj hormones los txhawb kev poob phaus thiab cov ntshav qab zib, Ozempic tsuas yog ua ib qho xwb.Retatrutide kuj zoo nkaus li txhawb kev poob phaus ntau dua li Ozempic. Kev tshawb fawb qhia tias Ozempic txhawb nqa qhov hnyav nruab nrab ntawm ib ncig ntawm 6 kg tom qab 40 lub lis piam.
Retatrutide pib ua haujlwm sai npaum li cas?
+
-
Retatrutide nyiam pib ua haujlwm hauv2 mus rau 4 hnub. Hauv Kev Kawm Phaj 2, qhov hnyav poob qis hauv thawj plaub lub lis piam yog li 2-5%, nyob ntawm qhov koob tshuaj.
Cim npe nrov: Tuam Tshoj Retatrutide txhaj 10 mg, Tuam Tshoj Retatrutide txhaj 10 mg manufacturers, lwm tus neeg
